Based on the available information, significant difference of age at diagnosis, race, grade, ER status, PR status, HER2 status, lymph node status, and surgical treatment were observed between patients with microinvasive carcinoma and DCIS. Here, ERBB2 is linked to ductal breast carcinoma in situ.